Journal: Cancer discovery

Article Title: Ricolinostat May Enhance Lenalidomide and Dexamethasone Efficacy.

PMID/MRN: 27807097

Publication Date: 2016-Nov-04

Abstract:

The HDAC6 inhibitor ricolinostat was well tolerated in combination therapy for multiple myeloma. ©2016 American Association for Cancer Research.